IFF Expands Latin American Footprint With New Enzyme Hub, Brazil Application Lab
MWN-AI** Summary
International Flavors & Fragrances Inc. (IFF) is making significant strides in the Latin American market by bolstering its Health & Biosciences (H&B) operations. The company has announced the transformation of its Arroyito site in Argentina into its first dedicated fermentation-based enzyme production hub in the region. Furthermore, IFF is inaugurating a household care application laboratory at its Innovation Center in Brazil. These developments are set to enhance IFF’s ability to deliver localized and rapid solutions for key sectors such as brewing, animal nutrition, biofuels, and home care.
Letícia Gonçalves, president of IFF H&B, emphasized the importance of these enhancements, stating that the integration of world-class fermentation processes will drive innovation for customers and contribute to improved quality in food and cleaning products. The Arroyito expansion focuses on producing high-performance enzymes through controlled biological processes that reduce environmental impact and enhance performance reliability.
Complementing this, the new application laboratory in Brazil allows for the evaluation and optimization of enzyme performance in actual regional conditions, streamlining testing processes for laundry and dishwashing products. This facility is pivotal for improving collaboration with clients and accelerating the development of next-generation cleaning solutions.
Deia Vilela, vice president of Latin America for IFF H&B, highlighted the dynamic growth of bioscience-enabled solutions in the region and the strengthening partnerships that will underpin future innovation and growth. IFF’s investment in Latin America underscores its commitment to enhancing its capabilities and solidifying its presence in high-growth areas across food, home care, personal care, and bio-industrial markets. This strategic move positions IFF favorably for ongoing growth in one of its most promising markets.
MWN-AI** Analysis
International Flavors & Fragrances (IFF) is strategically enhancing its presence in Latin America, particularly through the establishment of a full fermentation-based enzyme production hub in Arroyito, Argentina, and a household care application laboratory in Brazil. This development not only demonstrates IFF's commitment to innovation but also signals significant growth potential in the fast-expanding Health & Biosciences (H&B) sector.
The investment in local production capabilities aligns with IFF's broader objective of meeting increasing regional demand for bioscience-enabled solutions across various markets, including brewing, animal nutrition, and home care. The localized enzyme hub will help improve operational efficiency and product reliability, positioning IFF to adapt quickly to market dynamics. This agility is crucial as consumer preferences shift towards more sustainable and effective cleaning solutions and food products.
Analysts should note IFF's strategic move to enhance its production capabilities in Latin America as an indicator of long-term growth potential. By reducing reliance on imports and fostering closer relationships with customers, the company is likely to capture a larger share of the regional market. IFF's ability to produce high-performance enzymes using advanced fermentation technologies is a significant competitive advantage that should enhance its margins and profitability.
Investors considering IFF should monitor trends in demand for health and bioscience products in emerging markets. The ongoing expansion in Latin America, which represents one of the fastest-growing markets for IFF, indicates promising growth trajectories. As IFF enhances its innovation capabilities and customer collaboration, it is poised to benefit from increased market share and revenue growth.
In summary, IFF's investments in Latin America could signify a pivotal turn towards a more robust and sustainable growth phase, making the stock an attractive option for investors looking to capitalize on growth in the biosciences sector.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients and health & biosciences — is enhancing regional production and innovation capabilities to better support the continued growth of its Health & Biosciences (H&B) business in Latin America, one of the fastest-growing markets for the company. The effort includes the transformation of the Arroyito site in Argentina into IFF’s first full fermentation?based enzyme production hub in the region and the opening of a household care application laboratory at IFF’s Innovation Center in Brazil. Together, these enhancements expand IFF’s regional footprint and are expected to improve speed, reliability and locally relevant solutions for markets including brewing , animal nutrition , biofuels and home care .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260310253993/en/
IFF's home care application lab in Brazil.
“This is about turning science into impact where it matters most,” said Letícia Gonçalves, president of IFF H&B. “By bringing world?class fermentation and application capabilities to Latin America, we are accelerating innovation for our customers and translating that into better food, more effective cleaning solutions and everyday products that improve quality of life for millions of consumers across the region.”
Building a regional enzyme production hub
IFF’s deep expertise in fermentation technology is at the heart of the Arroyito expansion, enabling the production of high?performance enzymes through controlled biological processes that deliver consistent results under real?world manufacturing conditions while reducing environmental impact. With the enhancements, IFF will now produce enzymes locally from the initial biological stage rather than relying solely on final processing and packaging steps, improving performance reliability, increasing processing efficiency and enabling faster adjustments as customer needs evolve across applications including brewing, animal nutrition, biofuels and home care.
Advancing applied innovation in home and personal Care
Complementing the Arroyito plant transformation, IFF’s new household care application laboratory in Brazil is designed to help customers evaluate and optimize enzyme performance under real regional conditions. The laboratory supports laundry and dishwashing applications, enabling faster testing, improved formulation accuracy and closer collaboration with customers developing next?generation cleaning products.
“Latin America is a dynamic growth market for bioscience?enabled solutions,” said Deia Vilela, vice president of Latin America for IFF H&B. “What’s most exciting is how this momentum is being shaped through deeper partnerships with customers and teams across the region, creating a strong foundation for sustained innovation and shared growth in the years ahead.”
Building on more than four decades of industrial biotechnology leadership, IFF’s investment reinforces its long?term commitment to the region and positions its Health & Biosciences business to capture future growth across food, home and personal care, animal nutrition and bio?industrial markets.
Cautionary Statement under the Private Securities Litigation Reform Act of 1995
This press release contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “”plan”, “expect,” “anticipate,” “intend,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the timing or nature of the new facilities. The forward-looking statements included in this release are made only as of the date hereof, and we undertake no obligation to update the forward-looking statement to reflect subsequent events or circumstances.
Welcome to IFF
At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in taste, scent, food ingredients, health and biosciences, we’re innovating for the future. Every day, we deliver groundbreaking, sustainable solutions that elevate products people love — advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com , LinkedIn , Instagram and Facebook .
©2026 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260310253993/en/
Media Relations:
Paulina Heinkel
332.877.5339
Media.request@iff.com
Investor Relations:
Michael Bender
212.708.7263
Investor.Relations@iff.com
FAQ**
How does the enhancement of production capabilities at International Flavors & Fragrances Inc. IFF's Arroyito site position the company to meet the growing demand for bioscience-enabled solutions in Latin America?
What are the expected impacts of the new household care application laboratory in Brazil on product development and customer collaboration for International Flavors & Fragrances Inc. IFF?
In what ways does International Flavors & Fragrances Inc. IFF plan to leverage its fermentation technology to improve processing efficiency and reduce environmental impact in its Health & Biosciences business?
How is International Flavors & Fragrances Inc. IFF’s investment in Latin America indicative of its long-term commitment to capturing growth across various markets, including food, home care, and bio-industrial products?
**MWN-AI FAQ is based on asking OpenAI questions about Internationa Flavors & Fragrances Inc. (NYSE: IFF).
NASDAQ: IFF
IFF Trading
1.98% G/L:
$74.035 Last:
357,279 Volume:
$72.98 Open:
